From Casetext: Smarter Legal Research

Marquez v. Astrue

United States District Court, D. Idaho
Mar 22, 2011
Case No. 4:09-CV-515-CWD (D. Idaho Mar. 22, 2011)

Opinion

Case No. 4:09-CV-515-CWD.

March 22, 2011


MEMORANDUM DECISION AND ORDER


INTRODUCTION

Currently pending before the Court for its consideration is the Petition for Review (Dkt. 1) of the Respondent's denial of social security benefits, filed October 12, 2009, by Petitioner Grace H. Marquez ("Petitioner"). The Court has reviewed the Petition for Review and the Answer, the parties' memoranda, and the administrative record ("AR"), and for the reasons that follow, will remand to the Commissioner with further instructions.

PROCEDURAL AND FACTUAL HISTORY

Petitioner filed an application for Disability Insurance Benefits and Supplemental Security Income on February 15, 2007, alleging a disability onset date of January 1, 2005 due to low back pain, Hepatitis C infection, and arthritis. This application was denied initially and on reconsideration. A hearing was conducted on October 6, 2008, before Administrative Law Judge ("ALJ") G. Alejandro Martinez, who heard testimony from Petitioner and vocational expert Richard Taylor. ALJ Martinez issued a decision finding Petitioner not disabled on January 9, 2009, and Petitioner timely requested review by the Appeals Council, which denied her request for review on June 25, 2009.

Petitioner appealed this final decision to the Court. The Court has jurisdiction to review the ALJ's decision pursuant to 42 U.S.C. § 405(g). At the time of the hearing, Petitioner was 45 years of age. Petitioner completed the tenth grade and partially completed the eleventh grade. Petitioner's prior work experience includes work as a restaurant hostess, house manager, laborer, and case aid.

SEQUENTIAL PROCESS

The Commissioner follows a five-step sequential evaluation for determining whether a claimant is disabled. See 20 C.F.R. §§ 404.1520, 416.920. At step one, it must be determined whether the claimant is engaged in substantially gainful activity. The ALJ found Petitioner had not engaged in substantial gainful activity since her alleged onset date. At step two, it must be determined whether the claimant suffers from a severe impairment. The ALJ found Petitioner's low back disorder and Hepatitis C severe within the meaning of the Regulations.

Step three asks whether a claimant's impairments meet or equal a listed impairment. The ALJ found that Petitioner's impairments, specifically her Hepatitis C and resultant arthritis and low back disorder, did not meet or equal the criteria for the listed impairments. If a claimant's impairments do not meet or equal a listing, the Commissioner must assess the claimant's residual functional capacity ("RFC") and determine at step four whether the claimant has demonstrated an inability to perform past relevant work.

The ALJ found Petitioner was not able to perform her past relevant work as a restaurant hostess or house manager. If a claimant demonstrates an inability to perform past relevant work, the burden shifts to the Commissioner to demonstrate at step five that the claimant retains the capacity to make an adjustment to other work that exists in significant levels in the national economy, after considering the claimant's residual functional capacity, age, education and work experience. The ALJ determined, based upon Petitioner's RFC, that she retained the capacity to perform light work with certain restrictions. Even with the erosion to the base of light work, the ALJ found that Petitioner could perform work as a cashier or call out operator, both jobs that exist in significant numbers in the national economy. Therefore, the ALJ found Petitioner not disabled.

STANDARD OF REVIEW

Petitioner bears the burden of showing that disability benefits are proper because of the inability "to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which . . . has lasted or can be expected to last for a continuous period of not less than 12 months." 42 U.S.C. § 423(d)(1)(A); see also 42 U.S.C. § 1382c(a)(3)(A); Rhinehart v. Fitch, 438 F.2d 920, 921 (9th Cir. 1971). An individual will be determined to be disabled only if her physical or mental impairments are of such severity that she not only cannot do her previous work but is unable, considering her age, education, and work experience, to engage in any other kind of substantial gainful work which exists in the national economy. 42 U.S.C. § 423(d)(2)(A).

On review, the Court is instructed to uphold the decision of the Commissioner if the decision is supported by substantial evidence and is not the product of legal error. 42 U.S.C. § 405(g); Universal Camera Corp. v. Nat'l Labor Relations Bd., 340 U.S. 474 (1951); Meanel v. Apfel, 172 F.3d 1111, 1113 (9th Cir. 1999) (as amended); DeLorme v. Sullivan, 924 F.2d 841, 846 (9th Cir. 1991). Substantial evidence is such relevant evidence as a reasonable mind might accept as adequate to support a conclusion. Richardson v. Perales, 402 U.S. 389, 401 (1971). It is more than a scintilla but less than a preponderance, Jamerson v Chater, 112 F.3d 1064, 1066 (9th Cir. 1997), and "does not mean a large or considerable amount of evidence." Pierce v. Underwood, 487 U.S. 552, 565 (1988).

The Court cannot disturb the Commissioner's findings if they are supported by substantial evidence, even though other evidence may exist that supports the petitioner's claims. 42 U.S.C. § 405(g); Flaten v. Sec'y of Health and Human Servs., 44 F.3d 1453, 1457 (9th Cir. 1995). Thus, findings of the Commissioner as to any fact, if supported by substantial evidence, will be conclusive. Flaten, 44 F.3d at 1457. It is well-settled that, if there is substantial evidence to support the decision of the Commissioner, the decision must be upheld even when the evidence can reasonably support either affirming or reversing the Commissioner's decision, because the Court "may not substitute [its] judgment for that of the Commissioner." Verduzco v. Apfel, 188 F.3d 1087, 1089 (9th Cir. 1999).

When reviewing a case under the substantial evidence standard, the Court may question an ALJ's credibility assessment of a witness's testimony; however, an ALJ's credibility assessment is entitled to great weight, and the ALJ may disregard self-serving statements. Rashad v. Sullivan, 903 F.2d 1229, 1231 (9th Cir. 1990). Where the ALJ makes a careful consideration of subjective complaints but provides adequate reasons for rejecting them, the ALJ's well-settled role as the judge of credibility will be upheld as based on substantial evidence. Matthews v. Shalala, 10 F.3d 678, 679-80 (9th Cir. 1993).

DISCUSSION

Petitioner believes the ALJ erred at steps four and five in assessing Petitioner's RFC and her capacity to perform other work that exists in significant numbers in the national economy. Specifically, Petitioner argued that the ALJ erred by failing to properly evaluate Petitioner's credibility; failing to provide substantial evidence to support his RFC assessment; improperly rejecting Petitioner's treating physician's opinion; and failing to include all of Petitioner's limitations in the hypothetical posed to the vocational expert. Respondent contends that there was substantial evidence in the record for finding Petitioner's statements about the severity and limiting effects of her pain to be not credible, and that the ALJ's RFC assessment and the hypothetical posed to the vocational expert were sufficiently supported by credible evidence in the record. Specifically, the Respondent contends that the ALJ properly rejected Petitioner's treating physician's opinion because there was no objective medical evidence to corroborate his opinion.

1. Background

Petitioner contracted Hepatitis C when she was in her early twenties, likely from giving herself tattoos. (AR 300-301.) She worked as a restaurant hostess from November of 2006 until she voluntarily left employment in February of 2007 due to fatigue, back pain, and the resultant inability to complete her shift. (AR 106-124; 292.) Petitioner claims that she was not cleared to return to work without a physician's note, because she continually called in sick due to illness and medical appointments. (AR 124.)

Petitioner's medical history is limited due to her inability to afford medical care. (AR 294.) She was treated in the emergency room on January 11, 2007, complaining of severe low back pain for the previous three weeks that was radiating down her left side and had worsened. (AR 173.) Upon exam, she presented with a mild antalgic gait, and positive straight leg raise on the left. (AR 173.) An MRI ordered on January 11, 2007, indicated spondylolysis at L5-S1, with grade 1 spondylolisthesis, and spinal stenosis at L5-S1, particularly in the L5-S1 nerve root with mild facet joint hypertrophy. (AR 173, 174.) The MRI showed also a moderate broad-based disc bulge. (AR 174.) She was treated with an epidural steroid injection and pain medications. (AR 173.) After receiving the steroid injection, Petitioner's pain resolved from a level 8 to no pain. (AR 176.) However, Petitioner was seen again in the emergency room on February 16, 2007, suffering from acute burning and radiating low back pain. (AR 164.) Doctors on February 23, 2007, recommended surgery to correct her condition, but Petitioner stated she could not afford the treatment. (AR 162.) Emergency room physicians determined her low back pain was chronic in nature. (AR 162.)

Petitioner sought treatment from the Community Family Clinic ("Clinic") for her fatigue and management of her Hepatitis C beginning on September 5, 2006. (AR 210.) She presented with frequent urination, fatigue, lightheadedness, and joint pain over the previous two to three months. (AR 210.) Upon examination, it was noted that Petitioner had no hearing in her right ear. (AR 238.) Lab reports ordered on November 21, 2006, and December 6, 2006, indicated elevated liver enzymes and high lymph counts, with a resulting diagnosis of Hepatitis C. (AR 207-208.) Also on December 6, 2006, Petitioner sought treatment for leg cramps increasing in frequency and duration, and low back pain was noted upon physical exam. (AR 204.) She had good lower extremity joint range of motion and muscle strength. The physician's assessment was myalgias and fatigue related to Petitioner's abnormal thyroid study or Hepatitis C. (AR 204.)

On January 23, 2007, Petitioner sought follow up care from the Clinic for left side numbness and a gastroenterology consult. (AR 203.) It was noted at that time that continued treatment for her Hepatitis C would require normalization of her thyroid, which had low TSH and high T4 from previous lab studies. (AR 203.) Petitioner followed up on January 30, 2007. (AR 199.) At that time, physicians were concerned that Petitioner's treatment for Hepatitis C "could cause further hyperthyroidism." (AR 199.) Lab tests from January 30, 2007, indicated normal T4 and TSH levels, but high Reverse T3 and high Thyroxine levels. An ultrasound performed on January 25, 2007, indicated a normal thyroid without enlargement, with hyperthyrodism present. (AR 202.)

On February 2, 2007, Petitioner underwent a liver biopsy. (AR 168.) According to the biopsy report, Petitioner was suffering from chronic Hepatitis C, considered at Stage 2 with increased portal fibrosis and delicate ports to portal septae. (AR 169.)

On April 15, 2006, Petitioner sought emergency room treatment for shortness of breath. (AR 182.) Chest x-rays indicated her heart and lungs were within normal limits. (AR 182.) However, on July 15, 2007, chest x-rays showed a mildly enlarged heart indicative of mild congestive heart failure. (AR 189.)

Petitioner again sought treatment on November 29, 2007, at the Clinic complaining of fatigue, pain in her joints including her hips and wrists, and abdominal pain. (AR 188.) She had discontinued treatment for Hepatitis C. (AR 188.) Lab results from December 27, 2007, were negative for other causes of her fatigue, such as Lupus, West Nile, or Rheumatoid arthritis (AR 190, 195.) However, previous lab results from November 30, 2007, did show a high sedimentation rate, low white blood cell count, low neutrophils, high MCH, and other abnormalities. (AR 187.) Therefore, it was determined that the cause of her joint pain and fatigue was due to Hepatitis C. (AR 188.) A follow-up visit on December 5, 2007, indicated Petitioner was still complaining of fatigue, hot flashes, pain, chills and sweats, and presented with a flat affect. (AR 185.) Over the counter pain medications were reportedly insufficient to relive Petitioner's joint pain. (AR 185.)

On January 8, 2008, Petitioner was referred to Dr. Scoville, a rheumatologist. (AR 262-276.) Petitioner described her pain as having increased, with complaints of lower back pain for over one year. She described morning stiffness and soreness in her neck, shoulders, hands, wrists, lower back, and hips. Petitioner described her pain as a level 6 out of 10. Dr. Scoville noted she had been treated for Hepatitis C and was aware of her hyperthyroidism. Upon physical examination, Dr. Scoville observed a slight antalgic gait due to low back pain, mild tenderness of her SI joints and associated positive Patrick's test, tenderness in her thoracic spine and lumbar spine. As for her joint pain, Dr. Scoville observed slight to mild tenderness diffusely in her hands, wrists, elbows and shoulders. All joints had full range of motion with mild discomfort, although muscle strength was noted as below normal. (AR 268-70.) Petitioner had full fist formation and fair grasp with her hands. (AR 270.) Dr. Scoville noted also Petitioner's abnormal laboratory test results, including Petitioner's high sedimentation rate. (AR 271.) Dr. Scoville's assessment was chronic polyarthritis, malaise, fatigue, and low back pain. Although Dr. Scoville noted no evidence of rheumatoid arthritis, he diagnosed her rheumatic complaints as symptomatic of her Hepatitis C together with her hyperthyroidism. (AR 271.)

Petitioner returned to Dr. Scoville for a follow up on June 26, 2008. (AR 274.) Petitioner reported her symptoms had improved with drug therapy, but had worsened upon running out of her prescription medications. At that visit, Petitioner complained of pain at level 7 out of 10. Petitioner's last visit to Dr. Scoville on October 2, 2008, indicated no real change in Petitioner's complaints of joint soreness in her hands, shoulders, and low back, as well as fatigue. (AR 276-278). However, her range of motion was assessed as "good." (AR 278.) Dr. Scoville assessed that she suffered from chronic polyarthritis related to Hepatitis C. (AR 278.)

On July 14, 2008, Petitioner visited the Clinic for a follow-up visit. On that date, it was noted that she could not afford further treatment for her thyroid condition. (AR 221.) Range of motion in her wrists was noted as limited. (AR 221.) She had experienced weight loss, and was noted as having a fever and chills. (AR 221.)

On October 2, 2008, Dr. Scoville completed a Residual Functional Capacity Questionnaire and a questionnaire concerning whether Petitioner's arthritis met or equaled listing criteria. (AR 262-266.) In Dr. Scoville's opinion, Petitioner suffered from undefined polyarthritis with pain in her hands, shoulders, hips and back that would "often" interfere with work. (AR 262.) Specifically, Dr. Scoville opined that Petitioner would require excessive and unscheduled breaks depending upon her condition, and would be absent more than four times each month. In addition, Dr. Scoville was of the opinion that Petitioner would only be able to use her hands and fingers for 20% of an 8 hour day. (AR 264.) However, Petitioner could sit for 6 hours and stand for 2 hours each day. (AR 263.) As for meeting the listing criteria under Section 14.09 for inflammatory arthritis, Dr. Scoville noted five out of the six A Criteria were present, along with one B Criteria and three of four D criteria. (AR 266.)

Petitioner was assessed on September 11, 2008, by a physical therapist, Lynn Woodland. (AR 256.) She was referred specifically for an RFC evaluation. The therapist noted that Petitioner complained of fatigue and generalized pain in her muscles and joints, especially in her hands, hips, and shoulders, with pain worse in the mornings. (AR 256.) Upon examination and testing, the therapist found moderate limitations with her lumbar range of motion, and mild to moderate limitations in other joints consistent with Petitioner's complaints of arthritis type pain. (AR 257.) Mr. Woodland completed an RFC Questionnaire on September 11, 2008. (AR 261.) He noted Petitioner's prognosis as "guarded" due to her "rheumatoid arthritis," generalized muscle and joint pain, and fatigue. (AR 258.) In the therapist's opinion, Petitioner's symptoms would "frequently" interfere with attention and concentration, require excessive and unscheduled breaks, and the use of her hands, fingers, and arms would be limited throughout the day. (AR 259-60.) In addition, the therapist did not believe Petitioner was malingering, and she likely would be absent from work three to four times each month. (AR 260.)

During the hearing before the ALJ, Petitioner testified that her pain and joint stiffness was worse in the morning, thereby making it difficult to complete her morning routine. (AR 295.) Because of her fatigue, Petitioner testified she took frequent naps throughout the day. (AR 295.) Her joint stiffness in her hands caused pain in her fingers such that she had difficulty grasping or lifting objects, fingering a computer keyboard, and doing housework. (AR 296-302.) Petitioner lived with her son, who assisted her with cooking and housework. (AR 298.) Petitioner's testimony was consistent with the disability questionnaire she completed on April 8, 2007, indicating she had difficulty performing normal activities, and left her home only to go to her weekly doctor's appointments and to shop for food. (AR 142-49.)

They hypothetical given to the vocational expert during the hearing included Petitioner's impairments of Hepatitis C and low back disorder with "mild" resultant fatigue and pain. (AR 306.) Given an individual that could alternate sitting and standing throughout the day, walk occasionally, frequently use hands, fingers, fists, wrists, push and pull, with normal grip strength, fine dexterity, and normal manual dexterity in both hands, the vocational expert opined that someone with those limitations could not perform Petitioner's past relevant work, but could perform sedentary unskilled work such as a call out operator, information provider, or order clerk. (AR 308.) However, when the hypothetical included additional limitations such as limitations on using their hands for 20% of the day or less, missing work more than two days each month, or having to take additional, unscheduled breaks throughout the day, the vocational expert rendered the opinion that such an individual with any one of the above additional limitations would be precluded from all work.

2. Credibility

The ALJ is responsible for determining credibility, resolving conflicts in medical testimony, and resolving ambiguities. Reddick v. Chater, 157 F.3d 715, 722 (9th Cir. 1998). The ALJ's findings must be supported by specific, cogent reasons. Reddick, 157 F.3d at 722. If a claimant produces objective medical evidence of an underlying impairment, an ALJ may not reject a claimant's subjective complaints of pain based solely on lack of medical evidence. Burch v. Barnhart, 400 F.3d 676, 680 (9th Cir. 2005). See also Light v. Soc. Sec. Admin., 119 F.3d 789, 792 (9th Cir. 1997) (holding that an ALJ may not discredit a claimant's subjective testimony on the basis that there is no objective medical evidence that supports the testimony). Unless there is affirmative evidence showing that the claimant is malingering, the ALJ must provide clear and convincing reasons for rejecting pain testimony. Burch, 400 F.3d at 680. General findings are insufficient; the ALJ must identify what testimony is not credible and what evidence undermines the claimant's complaints. Reddick, 157 F.3d at 722.

The reasons an ALJ gives for rejecting a claimant's testimony must be supported by substantial evidence in the record. Regennitter v. Comm'r of Soc. Sec. Admin., 166 F.3d 1294, 1296 (9th Cir. 1999). If there is substantial evidence in the record to support the ALJ's credibility finding, the Court will not engage in second-guessing. Thomas v. Barnhart, 278 F.3d 957, 959 (9th Cir. 2002). When the evidence can support either outcome, the court may not substitute its judgment for that of the ALJ. Tackett v. Apfel, 180 F.3d 1094, 1098 (9th Cir. 1999).

When evaluating credibility, the ALJ may engage in ordinary techniques of credibility evaluation, including considering claimant's reputation for truthfulness and inconsistencies in claimant's testimony, or between claimant's testimony and conduct, claimant's daily activities, claimant's work record, and testimony from physicians and third parties concerning the nature, severity and effect of the symptoms of which claimant complains. Thomas v. Barnhart, 278 F.3d 947, 958-59 (9th Cir. 2002). Also, the ALJ may consider the location, duration and frequency of symptoms; factors that precipitate and aggravate those symptoms; the amount and side effects of medications; and treatment measures taken by the claimant to alleviate those symptoms. See Soc. Sec. Ruling 96-7p.

In this matter, the ALJ's negative credibility finding is not supported by substantial evidence. The ALJ relied upon Petitioner's "wide range of activities of daily living," such as household chores, personal care, cooking, laundry, cleaning, and shopping. (AR 19.) The ALJ cited three examples in the record. However, the ALJ selectively quoted and mischaracterized the record, and the records he did cite do not provide support for the ALJ's credibility finding.

Exhibit 4F (AR 237), upon which the ALJ relied, indicated only that Petitioner's sole form of exercise was "house chores," not that Petitioner did them frequently or with any vigor. In fact, Petitioner testified that her son lived with her, he did most of the chores, she only left her home to visit her doctor once each week or grocery shop with difficulty twice a month, and that it took her a long time to perform chores and self care because she had to "push [her] body" through the fatigue. ( See, e.g., AR 237, 268, 295, 296-302, 298, 142-49.) Petitioner's description of her lack of substantial daily activities was consistently reported to disability services in 2007, and to her treating physicians between 2006 and 2008. The mere fact that Petitioner has carried on "certain daily activities . . . does not in any way detract from her credibility as to her overall disability. One does not need to be `utterly incapacitated' in order to be disabled." Benecke v. Barnhart, 379 F.3d 587, 594 (9th Cir. 2004.)

The second reason the ALJ proffered for discounting Petitioner's credibility was the lack of medical records from any time since January 1, 2005, despite her claim that she was disabled since January 1, 2005, and had only described back pain since January of 2007. (AR 19.) Therefore, the ALJ concluded Petitioner was not afflicted with her impairments as early as alleged. However, the ALJ ignored Petitioner's diagnosis of chronic Hepatitis C, which Petitioner had been suffering from since 2005, and which caused her to leave employment in February of 2007. The record is replete with evidence that Petitioner sought treatment in September of 2006 for increasing problems related to fatigue, and was ultimately diagnosed with active and chronic Hepatitis C. The ALJ cannot, on the one hand, classify Petitioner's Hepatitis C as "severe" at step two, but ignore the symptoms associated with the condition when assessing Petitioner's credibility. Finally, the ALJ cited the lack of "objective evidence of [Petitioner's] pain" as a reason for doubting her credibility. This, too, was error. The ALJ cannot reject a claimant's subjective pain or symptom testimony "simply because the alleged severity of the pain or symptoms is not supported by objective medical evidence." Lingenfelter v. Astrue, 504 F.3d 1028, 1040 n. 11 (9th Cir. 2007). Moreover, the record does contain objective evidence, including documentation that Petitioner suffered from a bulging disc, walked with an antalgic gait, and had limitations with her range of motion in her low back. As for her fatigue and polyarthragias, again the record iss replete with medical documentation that Hepatitis C was the cause of these symptoms, as well as medical observation of Petitioner's discomfort, tenderness, and pain upon movement. ( See, e.g., AR 271.) While both Petitioner's treating rheumatologist and the examining physical therapist documented full range of motion in Petitioner's joints, the ALJ selectively did not mention that Petitioner experienced pain while doing so, nor did the ALJ consider Petitioner's fatigue as a result of Hepatitis C.

Accordingly, the Court finds the ALJ improperly discounted Petitioner's testimony about the limiting effects of her pain and symptoms. The ALJ did not provide clear and convincing reasons for discounting Petitioner's pain testimony, and his reasons were not supported by substantial evidence in the record.

3. Physician testimony

Ninth Circuit cases distinguish among the opinions of three types of physicians: (1) those who treat the claimant (treating physicians); (2) those who examine but do not treat the claimant (examining physicians); and (3) those who neither examine nor treat the claimant (nonexamining physicians). Lester v. Chatter, 81 F.3d 821, 830 (9th Cir. 1995). Generally, more weight is accorded to the opinion of a treating source than to nontreating physicians. Winans v. Bowen, 853 F.2d 643, 647 (9th Cir. 1987). If the treating physician's opinion is not contradicted by another doctor, it may be rejected only for "clear and convincing" reasons. Baxter v. Sullivan, 923 F.2d 1391, 1396 (9th Cir. 1991). If the treating doctor's opinion is contradicted by another doctor, the Commissioner may not reject the treating physician's opinion without providing "specific and legitimate reasons" supported by substantial evidence in the record for so doing. Murray v. Heckler, 722 F.2d 499, 502 (9th Cir. 1983). In turn, an examining physician's opinion is entitled to greater weight than the opinion of a nonexamining physician. Pitzer v. Sullivan, 908 F.2d 502, 506 (9th Cir. 1990); Gallant v. Heckler, 753 F.2d 1450 (9th Cir. 1984).

An ALJ is not required to accept an opinion of a treating physician if it is conclusory and not supported by clinical findings. Matney ex rel. Matney v. Sullivan, 981 F.2d 1016, 1019 (9th Cir. 1992). Additionally, an ALJ is not bound to a physician's opinion of a petitioner's physical condition or the ultimate issue of disability. Magallanes v. Bowen, 881 F.2d 747, 751 (9th Cir. 1989). If the record as a whole does not support the physician's opinion, the ALJ may reject that opinion. Batson v. Comm'r of Soc. Sec. Admin., 359 F.3d 1190, 1195 (9th Cir. 2004). Items in the record that may not support the physician's opinion include clinical findings from examinations, conflicting medical opinions, conflicting physician's treatment notes, and the claimant's daily activities. Id.; Bayliss v. Barnhart, 427 F.3d 1211 (9th Cir. 2005); Connett v. Barnhart, 340 F.3d 871 (9th Cir. 2003); Morgan v. Comm'r of Soc. Sec. Admin., 169 F.3d 595 (9th Cir. 1999).

Reports of treating physicians submitted relative to Petitioner's work-related ability are persuasive evidence of a claimant's disability due to pain and her inability to engage in any form of gainful activity. Gallant v. Heckler, 753 F.3d 1450, 1454 (9th Cir. 1984). Although the ALJ is not bound by expert medical opinion on the issue of disability, he must give clear and convincing reasons supported by substantial evidence for rejecting such an opinion where it is uncontradicted. Bayliss v. Barnhart, 427 F.3d 1211, 1216 (9th Cir. 2005); Gallant, 753 F.2d at 1454 (citing Montijo v. Secretary of Health Human Services, 729 F.2d 599, 601 (9th Cir. 1984); Rhodes v. Schweiker, 660 F.2d 722, 723 (9th Cir. 1981)). Clear and convincing reasons must also be given to reject a treating doctor's ultimate conclusions concerning disability, especially when they are not contradicted by another doctor. Lester v. Chater, 81 F.3d 821, 830 (9th Cir. 1995). The ALJ need not accept the opinion of any physician if the opinion is brief, conclusory, and inadequately supported by clinical findings. Thomas v. Barnhart, 278 F.3d 947, 957 (9th Cir. 2002).

In the instant case, the ALJ failed to give clear and convincing reasons for disregarding treating physician Dr. Scoville's diagnosis. The ALJ rejected Dr. Scoville's opinion because, while the medical evidence contained documentation of Petitioner's subjective complaints of joint pain, "there [was] no objective evidence, to include imaging studies, of arthritis in any of her joints," which the ALJ would have expected to see if Petitioner were indeed suffering from listing level arthritis. (AR 20.)

However, the record does contain objective evidence of Petitioner's arthritis. Dr. Scoville, a rheumatologist, diagnosed Petitioner with "undefined polyarthritis," and observed upon examination that Petitioner suffered pain in her joints. Dr. Scoville specifically noted Petitioner's abnormal laboratory results, especially her high sedimentation rate. Sedimentation rate is an accepted diagnostic tool for the diagnosis of polymyalgia rheumatica, and an extreme elevation is strongly indicative of serious underlying disease. Malcolm L. Brigden, M.D., B.C., CLINICAL UTILITY OF THE ERYTHROCYTE SEDIMENTATION RATE, American Family Physician (Oct. 1, 1999). The test is often used as a diagnostic parameter for rheumatoid arthritis. Id. Importantly, Dr. Scoville relied upon Petitioner's rheumatic complaints, diagnosis of Hepatitis C, and her abnormal laboratory results to conclude that Petitioner suffered from rheumatologic symptoms on the basis of her chronic Hepatitis C, but that the absence of synovitis in her joints did not suggest rheumatoid arthritis. Dr. Scoville believed Petitioner's rheumatic complaints met listing level requirements for arthritis. (AR 20.)

A specialist's opinion is given greater weight than those of other physicians because it is an "opinion of a specialist about medical issues related to his or her area of specialty." Benecke v. Barnhart, 379 F.3d at 594 n. 4 (citing 20 C.F.R. § 404.1527(d)(5)).

Found at http://www.aafp.org/afp/991001ap/1443.html, last visited on March 18, 2011, and attached hereto as Appendix 1.

The Court finds the ALJ erred in discounting Dr. Scoville's opinion as Petitioner's treating rheumatologist. There was objective evidence in the record, and the lack of imaging studies when Petitioner was expressly found not to be suffering from rheumatoid arthritis was an insufficient reason to disregard Dr. Scoville's diagnosis of polyarthritis. Therefore, the ALJ erred in his failure to fully credit Dr. Scoville's opinions about Petitioner's limitations and his opinion that Petitioner met the listing for arthritis.

4. Petitioner's Residual Functional Capacity

At the fourth step in the sequential process, the ALJ determines whether the impairment prevents the claimant from performing work which the claimant performed in the past, i.e., whether the claimant has sufficient residual functional capacity to tolerate the demands of any past relevant work. 20 C.F.R. §§ 404.1520(a)(4)(iv); 416.920(a)(4)(iv). A claimant's residual functional capacity is the most she can do despite her limitations. 20 C.F.R. § 404.1545(a). An ALJ considers all relevant evidence in the record when making this determination. Id. Generally, an ALJ may rely on vocational expert testimony. 20 C.F.R. § 404.1566(e); Bayliss v. Barnhart, 427 F.3d 1211, 1218 (9th Cir. 2005). An ALJ must include all limitations supported by substantial evidence in his hypothetical question to the vocational expert, but may exclude unsupported limitations. Bayliss, 427 F.3d at 1217. The ALJ need not consider or include alleged impairments that have no support in the record. See Osenbrock v. Apfel, 240 F.3d 1157, 1163-64 (9th Cir. 2000).

Here, the ALJ erred by failing to include all of Petitioner's impairments in the hypothetical posed to the vocational expert. By improperly weighting Dr. Scoville's opinion concerning Petitioner's arthritic complaints and limitations, and specifically Dr. Scoville's opinion that Petitioner would be limited in the use of her arms, hands, and fingers because of such complaints and would miss more than two days of work each month, the hypothetical posed did not include those impairments. Rather, by discounting Dr. Scoville's opinion, the hypothetical included only "mild" fatigue and pain and the ability to "frequently" use hands, fingers, fists, and wrists. Under such circumstances, the vocational expert opined that Petitioner was capable of sedentary unskilled work such as a cashier or order clerk.

However, when asked if someone afflicted with arthritis who could only use their hands 20% of the day, or less than occasionally, could perform the identified jobs, the vocational expert was of the opinion that such individual would be precluded from performing those occupations. (AR 309.) In addition, Dr. Scoville was of the opinion that Petitioner would miss more than two days of work each month. Petitioner testified also that because of her arthritic symptoms and fatigue, she had difficulty performing her morning routine, and would likely be late to work consistently. (AR 310.)

By discounting Dr. Scoville's opinion, the ALJ failed to include these limitations in the hypothetical to the vocational expert, and committed error.

Petitioner complained also that the ALJ improperly rejected Petitioner's hearing impairment. However, only one treatment note on September 5, 2006, mentioned Petitioner's lack of hearing in her right ear, with no other physician or medical care provider mentioning any subjective complaints related to Petitioner's hearing impairment. (AR 237-238.) No objective evidence appeared in the record to document Petitioner's hearing loss. Because the Court determines that it was error to not fully credit Dr. Scoville's opinion, with the result that the hypothetical did not include all of Petitioner's impairments supported by the record, the Court does not reach the issue of Petitioner's hearing impairment on appeal.

CONCLUSION

Based upon the foregoing review of the record, the ALJ's reasons for finding Petitioner to be not fully credible and for according Petitioner's treating rheumatologist's opinion little weight are not supported by substantial evidence in the record as a whole. As a result, the hypothetical posed to the vocational expert did not include all of Petitioner's limitations. Therefore, the ALJ's conclusion that Petitioner is not disabled is the product of legal error and will be remanded.

ORDER

NOW THEREFORE IT IS HEREBY ORDERED:
1) Plaintiff's Petition for Review (Dkt. 1) is GRANTED.
2) This action shall be REMANDED to the Commissioner for further proceedings consistent with this opinion.
3) This Remand shall be considered a "sentence four remand," consistent with 42 U.S.C. § 405(g) and Akopyan v. Barnhart, 296 F.3d 852, 854 (9th Cir. 2002).

Appendix 1

Please note: American Family Physician American Family Physician About Us News Journals Members CME Center Clinical Research Running a Practice Policy Advocacy The Web archive extends from 1998 to the present. Enhanced features are available for content published after 2000. PUBLISHED BY THE AMERICAN ACADEMY OF FAMILY PHYSICIANS OCTOBER 1, 1999

Clinical Utility of the Erythrocyte Sedimentation Rate

MALCOLM L. BRIGDEN, M.D., B.C.

Cancer Agency, Kelowna, British Columbia, Canada

The erythrocyte sedimentation rate (ESR) determination is a commonly performed laboratory test with a time-honored role. However, the usefulness of this test has decreased as new methods of evaluating disease have been developed. The test remains helpful in the specific diagnosis of a few conditions, including temporal arteritis, polymyalgia rheumatica and, possibly, rheumatoid arthritis. It is useful in monitoring these conditions and may predict relapse in patients with Hodgkin's disease. Use of the ESR as a screening test to identify patients who have serious disease is not supported by the literature. Some studies suggest that the test may be useful as a "sickness index" in the elderly or as a screening tool for a few specific infections in certain settings. An extreme elevation of the ESR is strongly associated with serious underlying disease, most often infection, collagen vascular disease or metastatic malignancy. When an increased rate is encountered with no obvious clinical explanation, the physician should repeat the test after an appropriate interval rather than pursue an exhaustive search for occult disease. (Am Fam Physician 1999;60:1443-50.)

The erythrocyte sedimentation rate (ESR) determination is a simple and inexpensive laboratory test that is frequently ordered in clinical medicine.1-3 The test measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The basic factors influencing the ESR have been understood since the early part of this century; the amount of fibrinogen in the blood directly correlates with the ESR. The most satisfactory method of performing the test was introduced by Westergren in 1921.1 Although there is an enormous body of literature concerning the ESR, an elevated value remains a nonspecific finding.3

Physiologic Basis for the Test

Reference ranges for the ESR are provided in Table 1. 4 As with other laboratory tests, the actual reference range used for the ESR should be established by the laboratory performing the test. Women tend to have higher ESR values, as do the elderly.2 For unknown reasons, obese people have also been noted to have slightly elevated ESRs, although this is not thought to have clinical significance.3 Other factors that may influence the ESR are detailed in Table 2. TABLE 1 Upper limit of reference range Adults (mm/hr)

Reference Ranges for the ESR in Healthy Adults Age 50 years 0 to 15 Men 0 to 20 Women Age 50 years 0 to 20 Men 0 to 30 Women ESR = erythrocyte sedimentation rate. Information from Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967;2:85-7.

Any condition that elevates fibrinogen (e.g., pregnancy, diabetes mellitus, end-stage renal failure, heart disease, collagen vascular diseases, malignancy) may also elevate the ESR.3 Anemia and macrocytosis increase the ESR. In anemia, with the hematocrit reduced, the velocity of the upward flow of plasma is altered so that red blood cell aggregates fall faster. Macrocytic red cells with a smaller surface-to-volume ratio also settle more rapidly.

A decreased ESR is associated with a number of blood diseases in which red blood cells have an irregular or smaller shape that causes slower settling.1.3

In patients with polycythemia, too many red blood cells decrease the compactness of the rouleau network and artifactually lower the ESR. An extreme elevation of the white blood cell count as observed in chronic lymphocytic leukemia has also been reported to lower the ESR.1.5 Hypofibrinogenemia, hypergammaglobulinemia associated with dysproteinemia, and hyperviscosity may each cause a marked decrease in the ESR. Although it has been reported that drug therapy with aspirin or other nonsteroidal anti-inflammatory agents may decrease the ESR, this has been disputed.2,3

Because the ESR determination is frequently performed in office laboratories, careful attention to technical factors that may produce erroneous values is important (Table 2). A tilted ESR tube will cause an artifactual elevation, whereas inadequate anticoagulation with clotting of the blood sample will consume fibrinogen and may artifactually lower the ESR.1.2

Researchers have wondered whether other tests, such as measurement of C-reactive protein, may perform better than the ESR.6-8 Repeatedly, the ESR and plasma viscosity determinations have been shown to be the most satisfactory monitors of acute-phase response to disease after the first 24 hours.6,8 During the first 24 hours in an inflammatory process, C-reactive protein may be a better indicator of the acute phase response.6 However, C-reactive protein tests are more expensive, less widely available and more time-consuming to perform than the ESR.2,7.8 Advantages and disadvantages of these three tests are summarized in Table 3. TABLE 2 Factors That May Influence ESR Factors with no clinically significant Factors that effect or questionable increase ESR Factors that decrease ESR effect

Old age Extreme leukocytosis Obesity Female Polycythemia Body temperature Pregnancy Red blood ceil abnormalities Recent meal Anemia Spherocytosis Aspirin Red blood cell Acanthocytosis NSAIDs abnormalities Microcytosis Macrycytosis Technical factors Technical factors Dilutional problem Dilutional problem Inadequate mixing Increased Clotting of blood sample temperature of Short ESR tube specimen Vibration during testing Tilted ESR tube Protein abnormalities Elevated fibrinogen Hypofibrinogenemia level Hypogammaglobulinemia Infection Dysproteinemia with Inflammation hyperviscosity state Malignancy NSAIDs = nonsteroidal anti-inflammatory drugs; ESR = erythrocyte sedimentation rate.

Using the ESR to Make a Diagnosis

The ESR remains an important diagnostic criterion for only two diseases: polymyalgia rheumatica and temporal arteritis9-11 (Table 4). Polymyalgia rheumatica is characterized by severe aching and stiffness in the neck, shoulder girdle or pelvic girdle areas.10 In some The ESR remains an important diagnostic criterion only for polymyalgia rhuematica and temporal arteritis.

patients, systemic symptoms may predominate, with initial manifestations including anemia, fever of unknown origin or a nonspecific systemic illness accompanied by anorexia, malaise and weight loss.

Temporal arteritis is usually characterized by headaches, visual disturbances such as blindness, a tender, reddened or nodular temporal artery, facial pain and jaw claudication.11 Extracranial vasculitis sometimes is associated with temporal arteritis and may present with symptoms affecting the liver, kidneys or peripheral nervous system. Systemic manifestations including anemia, fever, weight loss, malaise and an abnormal alkaline phosphatase value are frequently present.10

Nearly all patients who have temporal arteritis will have an elevated ESR; however, an occasional patient may present with a normal value.9 One study found that the average ESR was greater than 90 mm per hour in patients who had temporal arteritis, with values exceeding 30 mm per hour in 99 percent of the cases.12 However, if there is solid clinical evidence of temporal arteritis, a normal ESR value should be disregarded, and the patient should undergo a temporal artery biopsy or an empiric trial of corticosteroid therapy.9

The ESR traditionally has been a diagnostic parameter for rheumatoid arthritis, but it is used as a means of staging the disease rather than as one of the major diagnostic criteria.3,13 The American Rheumatism Association criteria include an elevated ESR as one of 20 findings that may be present.3 Most rheumatologists believe that careful joint examination confirming synovitis constitutes a more important diagnostic criterion. However, the ESR may still be useful if the diagnosis is questionable and definite evidence of inflammation might affect therapeutic decisions.13

Monitoring Disease Activity or Response to Therapy

In the past, the ESR was commonly used as an index of disease activity in patients who had certain disorders. With the development of more specific methods of evaluation, the ESR has remained an appropriate measure of disease activity or response to therapy for only a few diseases: temporal arteritis, polymyalgia rheumatica, rheumatoid arthritis and, possibly, Hodgkin's disease.1-3 TABLE 3 Test Advantages Disadvantages

Comparison of the ESR, C- reactive Protein and Plasma Viscosity Tests ESR Inexpensive, Affected by a quick, simple to variety of perform factors, including anemia and red blood cell size; not sensitive enough for screening C- Most rapid Wide reference reactive response to range may protein inflammation necessitate (complementary sequential to ESR in this recording of regard) values, expensive, batch processing may delay individual results Plasma Unaffected by Expensive, not viscosity anemia or red widely blood cell size available, technically cumbersome to perform ESR = erythrocyte sedimentation rate. In following the response to therapy in temporal arteritis and polymyalgia rheumatica, the ESR may not always give a clear indication of disease activity. Therefore, patients should be monitored by ESR values and clinical findings.10-12 For example, when corticosteroid therapy is started for temporal arteritis or polymyalgia rheumatica, the ESR usually drops within a few days. In many patients the ESR will stop at a higher-than-normal level, even if the patient's clinical status has dramatically improved.3 For this reason, an elevated ESR in a patient who has established temporal arteritis or polymyalgia rheumatica should not be used as the sole rationale for maintaining or increasing steroid therapy if the patient is doing well clinically. The converse is also true, because clinical relapse can occur in the face of a normal ESR finding.9

In rheumatoid arthritis, the ESR tends to reflect clinical disease activity but usually mirrors other symptoms such as morning stiffness or fatigue.3,5 Joint examination is considered more useful in assessing synovitis. In one study, the ESR level that best distinguished patients with rheumatoid arthritis in remission from those with active disease was less than 20 mm per hour for men and less than 30 mm per hour for women.5 However, other studies have shown that a significant proportion of patients in clinical remission may still have an elevated ESR value.1.3

Oncologic Diseases

In oncology, a high ESR has been found to correlate with overall poor prognosis for various types of cancer, including Hodgkin's disease, gastric carcinoma, renal cell carcinoma, chronic lymphocytic leukemia, breast cancer, colorectal cancer and prostate cancer.3,14-16 In patients with solid tumors, a sedimentation rate greater than 100 mm per hour usually indicates metastatic disease, but for most tumors this relatively nonspecific finding has been supplanted by more precise diagnostic tests. However, European studies of patients with Hodgkin's disease have suggested that an elevated ESR may still be an excellent predictor of early relapse, especially if the value remains elevated after chemotherapy or fails to drop to a normal level within six months after therapy.3,16 Certainly, an increased ESR should never be used as the sole criterion for diagnosing relapsed Hodgkin's disease.

Discriminating Iron Deficiency from Anemia of Chronic Disease

The ESR may be useful in differentiating iron deficiency from anemia of chronic disease in patients with a background chronic inflammatory condition such as rheumatoid arthritis.17,18 Iron deficiency anemia and anemia of chronic disease are hyporegenerative and characterized by a low reticulocyte count. Unfortunately, neither iron studies nor serum ferritin levels are definitive in distinguishing between these two types of anemia. Because both may have a transferrin saturation of around 15 percent, simply evaluating the serum iron level and percent saturation will not differentiate between the two conditions. Similarly, an individual serum ferritin level may not be helpful when inflammation is present because ferritin is an acute phase reactant and may be artifactually elevated.17 In the past, the final arbitrator in this situation has been bone marrow aspiration with Prussian blue staining to determine the presence of iron. The probability of iron deficiency can usually be established by correcting an individual ferritin value for the degree of coexistent inflammation as indicated by the ESR, possibly avoiding a bone marrow examination.18 A nomogram for this purpose is provided in Figure 1. 18 TABLE 4

Utility of the ESR: Key Considerations • The ESR is an inexpensive, simple test of chronic inflammatory activity. • Indications for the ESR have decreased as the sophistication of laboratory testing has increased. • The ESR rises with age, but this increase may simply reflect a higher disease prevalence in the elderly. • The use of the ESR as a screening test in asymptomatic persons is limited by its low sensitivity and specificity. • An elevated ESR is a key diagnostic criterion for polymyalgia rheumatica and temporal arteritis, but normal values do not preclude these conditions. • When there is a moderate suspicion of disease, the ESR may have some value as a "sickness index." • An extremely elevated ESR ( 100 mm/hr) will usually have an apparent cause — most commonly infection, malignancy or temporal arteritis. • A mild to moderately elevated ESR without obvious etiology should prompt repeat testing after several months rather than an expensive search for occult disease. ESR = erythrocyte sedimentation rate.

Screening for Systemic Disease or Neoplasia

Unfortunately, the ESR is neither sensitive nor specific when used as a general screening test.13,19 For instance, the ESR may be elevated in the presence of infectious disease, other inflammatory or destructive processes, collagen vascular disease or malignancy,1-3 but it may not be increased in a number of infectious diseases (e.g., typhoid fever, malaria, mononucleosis), allergic processes, angina (as opposed to myocardial infarction) or peptic ulcer disease (as opposed to active inflammatory bowel disease).

Because an elevated ESR may occur in so many different clinical settings, this finding is meaningless as an isolated laboratory value. In addition, some patients who have malignant tumors, infections or other inflammatory disorders will have normal ESR values. Most unexplained ESR elevations are short-lived and not associated with any specific underlying process. In those instances where disease is present, it will usually be obvious after completion of history taking, physical examination and collection of routine laboratory data.3

Although an elevated ESR may occur with many types of cancer, it rarely indicates an occult tumor because most of these patients have widely metastatic disease.3,14,16 For this reason, when a mild to moderate elevation of the ESR (less than 100 mm per hour) is encountered in an asymptomatic patient, simply repeating the test at some future time should be considered in the absence of other clinical findings.3 No evidence suggests that an elevated ESR that is unsubstantiated by history, physical examination or other findings

In patients with solid tumors, an ESR greater than 100 mm per hour usually indicates metastatic disease.

should trigger an extensive laboratory or radiographic work-up or invasive diagnostic procedures.1-3

Screening for Infection in Specific Clinical Settings

Recent studies have evaluated the ESR as a screening test for infection in specific clinical instances such as infection associated with orthopedic prostheses, pediatric bacterial infection and gynecologic inflammatory disease.6,7,20 Although frequently abnormal in patients who have an infected prosthesis, the ESR value is not as sensitive or specific an indicator of infection as joint aspiration.20 Elevation of the ESR has been proposed as a clue to the presence of an invasive bacterial infection in children after the first 48 hours of symptoms.6 In one investigation,7 the ESR more accurately indicated the severity of acute pelvic inflammatory disease than did the physical examination, thus helping to evaluate patients who required antimicrobial therapy. The appropriateness of the ESR as a screening test for infection, even in these well-defined clinical settings, requires further evaluation.

Exhibit

Usefulness as a Sickness Index in the Elderly

Some authors have proposed that the ESR be used as an inexpensive "sickness index" in the elderly.19,21 In a study of 142 residents of a long-term care hospital who had a nonspecific change in health status or developed new musculoskeletal complaints, the post-test probability of new disease rose from 7 percent in those with an ESR of less than 20 mm per hour to 66 percent in those with an ESR of more than 50 mm per hour. However, this investigation specifically excluded patients known to have an ESR-elevating disease and those in whom no disease was suspected.21

The authors concluded that combining clinical evaluation with an individual ESR value allowed the identification of groups of patients in whom the likelihood of disease was quite low or reasonably high, possibly limiting unnecessary investigations. TABLE 5

Possible Testing in an Asymptomatic Patient with a Markedly Elevated ESR* • PPD testing • Chest radiograph • Hematology profile • Creatinine and urea nitrogen measurements • Liver function studies • Urinalysis • Serum and urine protein electrophoresis • Occult blood testing of stool ESR = erythrocyte sedimentation rate; PPD = purified protein derivative. * — 100 mm per hr.

Extreme Elevation of the ESR

An extreme elevation of the ESR (defined as greater than 100 mm per hour) is associated with a low false-positive rate for a serious underlying disease.22,23 The conditions found in this situation have varied in individual populations, depending on patient age and inpatient versus outpatient status. In most series, infection has been the leading cause of an extremely elevated value, followed by collagen vascular disease and metastatic malignant tumors.22 Renal disease has also been a notable etiologic factor.3

Because most of these conditions are clinically apparent, any tests performed should be clinically driven. For instance, if symptoms of infection are present, the appropriate cultures, including urine and blood, and skin testing for tuberculosis should be obtained.22,23 An exhaustive search for an occult malignancy should not be undertaken because, if cancer is present, it is almost always metastatic.1,3

No obvious cause is apparent in fewer than 2 percent of patients with a markedly elevated ESR. In such patients, the history and physical examination coupled with readily available tests (Table 5) will usually establish the etiology. Because a notable number of patients with an ESR greater than 100 mm per hour have myeloma or some other type of dysproteinemia, urine and serum protein electrophoretic studies should be included in the testing.3

An elevated ESR in the absence of other findings should not trigger an extensive laboratory or radiographic evaluation.

The Author

MALCOLM L. BRIGDEN, M.D.

is currently an associate professor of medicine on the faculty of medicine and health sciences of United Arab Emirates University, Al Ain. He was formerly a senior medical oncologist at the B.C. Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada. A graduate of McGill University Medical School, Montreal, Dr. Brigden received postgraduate training in hematology/oncology at the University of Edmonton, Alberta, and the Mayo Clinic, Rochester, Minn.

Address correspondence to Malcolm L. Brigden, M.D., United Arab Emirates University, Faculty of Medicine and Health Sciences, P.O. Box 17666, Al Ain, United Arab Emirates. Reprints are not available from the author.

REFERENCES

1. Saadeh C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J 1998; 3:220-5. 2. Brigden M. The erythrocyte sedimentation rate: still a helpful test when used judiciously. Postgrad Med 1998; 103:257-74. 3. Sox HC Jr, Liang MH. The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med 1986; 104:515-23. 4. Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967; 2:85- 7. 5. Wolfe F. Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994; 21:1227-37. 6. Stuart J, Whicher JT. Tests for detecting and monitoring the acute phase response. Arch Dis Child 1988; 63:115-7. 7. Miettinen AK, Heinonen PK, Laippala P, Paavonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 1993; 169:1143-9. 8. Katz PR, Karuza J, Gutman SI, Bartholomew W, Richman G. A comparison between erythrocyte sedimentation rate (ESR) and selected acute-phase proteins in the elderly. Am J Clin Pathol 1990; 94:637-40. 9. Wise CM, Agudelo CA, Chmelewski WL, McKnight KM. Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 1991; 34:1571-4. 10. Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica: clinical and biopsy findings. Ann Intern Med 1972; 77:845-52. 11. Goodman BW Jr. Temporal arteritis. Am J Med 1979; 67:839-52. 12. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978; 88:162-7. 13. Weinstein A, Del Giudice J. The erythrocyte sedimentation rate: time honored and tradition bound [Editorial]. J Rheumatol 1994; 21:1177-8. 14. Ljungberg B, Grankvist K, Rasmuson T. Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995; 76:1435-9. 15. Johansson JE, Sigurdsson T. Holmberg L, Bergstrom R. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer: an analysis of prognostic factors in 300 population-based consecutive cases. Cancer 1992; 70:1556-63. 16. Henry-Amar M, Friedman S, Hayat M, Somers R, Meerwaldt JH, Carde P, et al. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin's disease. Ann Intern Med 1991; 114:361-5. 17. Brigden ML. Iron deficiency anemia: every case is instructive. Postgrad Med 1993; 93:181-92. 18. Witte DL, Angstadt DS, Davis SH, Schrantz RD. Predicting bone marrow iron stores in anemic patients in a community hospital using ferritin and erythrocyte sedimentation rate. Am J Clin. Pathol 1988; 90:85-7. 19. Smith EM, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med 1994; 51:394-7. 20. Thoren B, Wigren A. Erythrocyte sedimentation rate in infection of total hip replacements. Orthopedics 1991; 14:495-7. 21. Tinetti ME, Schmidt A, Baum J. Use of the erythrocyte sedimentation rate in chronically ill, elderly patients with a decline in health status. Am J Med 1986; 80:844-8. 22. Fincher RM, Page MI. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch Intern Med 1986; 146:1581-3. 23. Lluberas-Acosta G, Schumacher HR Jr. Markedly elevated erythrocyte sedimentation rates: consideration of clinical implications in a hospital population. Br J Clin Pract 1996; 50:138-42.


Summaries of

Marquez v. Astrue

United States District Court, D. Idaho
Mar 22, 2011
Case No. 4:09-CV-515-CWD (D. Idaho Mar. 22, 2011)
Case details for

Marquez v. Astrue

Case Details

Full title:GRACE H. MARQUEZ, Petitioner, v. MICHAEL J. ASTRUE, Commissioner of Social…

Court:United States District Court, D. Idaho

Date published: Mar 22, 2011

Citations

Case No. 4:09-CV-515-CWD (D. Idaho Mar. 22, 2011)